Concord Medical Services (NYSE:CCM) Research Coverage Started at StockNews.com

Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Performance

NYSE CCM opened at $7.01 on Friday. Concord Medical Services has a fifty-two week low of $3.82 and a fifty-two week high of $26.70. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.32 and a quick ratio of 0.30. The business’s 50 day moving average price is $6.67 and its 200-day moving average price is $6.78.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.